Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics

Chest

Volumn 129, Issue 6, 2006, Pages 1492-1499

  Gelb, Arthur F ^a,c   Taylor, Colleen Flynn ^a   Shinar, Chris M ^a   Gutierrez, Carlos ^b   Zamel, Noe ^b  

^a Lakewood Regional Medical Center   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (United States)

Author keywords

Asthma exacerbations; Exhaled nitric oxide; Spirometry

Indexed keywords

FLUTICASONE; IPRATROPIUM BROMIDE; NITRIC OXIDE; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LARGE AIRWAY NITRIC OXIDE FLUX; MALE; MANTEL HAENSZEL TEST; MEASUREMENT; NEGATIVE PREDICTIVE VALUE; POSITIVE PREDICTIVE VALUE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK; RISK ASSESSMENT; SMALL AIRWAY ALVEOLAR NITRIC OXIDE FLUX; SPIROMETRY; STATISTICAL MODEL; STATISTICAL PARAMETERS; TOTAL EXHALED NITRIC OXIDE;

EID: 33745175856     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.6.1492     Document Type: Article

References (46)

1. Rabe KF, Vermeire PA, Soriano J, et al. Clinical management of asthma in 1999: the Asthmatics Insights and Reality in Europe (SAIRE) study. Eur Respir J 2000; 16:802-807
2. Pendergraft TB, Stanford RH, Beasley R, et al. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol 2004; 93:29-35
3. Gelb AF, Schein A, Nussbaum E, et al. Risk factors for near-fatal asthma. Chest 2004; 126:1138-1146
4. Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the Epidemiology and National History of Asthma, Outcomes, and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-manage asthma. Ann Allergy Asthma Immunol 2004; 92:32-39
5. Stempel DA. The myth of mild asthma. Ann Allergy Asthma Immunol 2002; 89:340-343
6. 1 is associated with risk of asthma attacks in long-term follow up. Chest 2004; 126:1875-1882
7. Kharitonov SA, Gonio F, Kelly C, et al. Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children, Eur Respir J 2003; 21:433-438
8. Kharitonov SA, Barnes PJ. Inhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722
9. Dupont IJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003; 123:751-756
10. Deykin A, Massaro AF, Drazen JM, et al. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med 2002; 165:1597-1601
11. Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004; 169:473-478
12. Berkman N, Avitol A, Breuer R, et al. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 2005; 60:383-388
13. Sandrini A, Ferreira I, Gutierrez C, et al. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 2003; 124:1334-1340
14. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164:738-743
15. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163:406-412
16. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72
17. Pijnenberg MW, Hofhuis W, Hop WC, et al. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax 2005; 60:215-218
18. Stirling RG, Kharitonov SA, Campbell D, et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Thorax 1998; 53:1030-1034
19. Green RH, Brighting CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts in randomized controlled trial. Lancet 2002; 360:1715-1721
20. Covar RA, Szefler SJ, Martin RJ, et al. Relation between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142:469-475
21. Gelb AF, Flynn Taylor C, Nussbaum E, et al. Alveolar and airway sties of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med 2004; 170:737-741
22. van Rensen EL, Straathof KC, Vaselic-Charvat MA, et al. Effect of inhaled steroids on airway hyperresponsiveness, sputa eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 1999; 54:403-408
23. Smith AD, Cowan, JD, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-2173
24. Lehtimaki L, Kankaanranta H, Saarelainen S, et al. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001; 18:635-639
25. Lim S, Jatakanon A, Meah S, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000; 55:184-188
26. Berry M, Hargadon B, Morgan A, et al. Alveolar nitric oxide in adults with asthma. Eur Respir J 2005; 25:986-991
27. Payne DNR, Adcock IA, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001; 164:1376-1381
28. Ricciardolo FM. Multiple roles of nitric oxide in the airways. Thorax 2003; 58:175-182
29. Hamid Q, Springall DR, Riveres-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342:1510-1513
30. National Asthmatic Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 1997; Publication No. 97-4051
31. British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network. British guidelines on the management of asthma. Thorax 2003; 58:i1-i94
32. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002. Publication No. 02-3659
33. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930
34. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations: the European Respiratory Society Task Force. Eur Respir J 1997; 10:1683-1693
35. Silkoff PE, McClean PA, Slutsky AS, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997; 155:260-267
36. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998; 85:653-666
37. Gelb AF, Zamel N. Unsuspected pseudophysiologic emphysema in chronic persistent asthma. Am J Respir Crit Care Med 2000; 162:1778-1782
38. Gelb AF, Licuanan J, Shinar CM, et al. Unsuspected loss of lung elastic recoil in chronic persistent asthma. Chest 2002; 121:715-721
39. Harkins MS, Fiato K-L, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41:1-6
40. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 190:410-418
41. Bateman ED, Boushey H, Bousquet J, et al. Can guideline-defined asthma control be achieved: the Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004; 170:836-844
42. Antic R, Macklem PT. The influence of clinical factors on site of airway obstruction in asthma. Am Rev Respir Dis 1976; 114:851-859
43. Miranda C, Busacker A, Balzar S, et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004; 113:101-108
44. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154:1505-1511
45. Mauad T, Xavier AC, Saldiva PH, et al. Elastosis and fragmentation of fibers of the elastic system in fatal asthma. Am J Respir Crit Care Med 1999; 160:968-975
46. Mauad T, Silva LFF, Santos MA, et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med 2004; 170:857-862